How many ended due to control arm outperforming all historical benchmarks. Like I said, my concern with small bios going alone is the system which includes the corrupt FDA and the corrupt BPs.
I think AFs rule of no bio has ever had a successful ph3 going it alone if they had mkt cap of less than $300M. Just a coincidence? I don't think so.
They better partner or they will never get approved.
News 
Market Data 
Discover 
